An obesity doctor walks through how the various GLP-1 drugs differ, shared as a reposted video on X.
Recap by typeshit. Post by Salman Khan on X.
Centre Daily Times looks at how peptides taken by mouth can get past the gut intact and reach specific spots in the body, a key hurdle for pill versions of these drugs.
18:20
Dr. Lindsay Ogle, an MD who covers metabolic health, talks through options for people whose appetite hasn't settled on GLP-1 treatment.
A short post credits scientists with finding axolotl peptides that kill breast cancer cells. It names no study or team, so treat it as an early claim.
Pratt, a psychology professor who studies the circuits behind food motivation, walks through what neuroscience shows about these drugs.
Polskie Radio looks at a newer weight loss drug being framed as a successor to Ozempic. The material is thin, so tap through for which drug it is.
Her view is that quicker loss on retatrutide doesn't automatically mean improved metabolic health. It's a short opinion post with no new data behind it.
Loading…